6.56

2.96% -0.20

After Hours: 6.50 -0.06 -0.91%

Bausch Health Companies Inc (BHC)

Overview News Price History Option Chain Financials Why BHC Down? Discussions Forecast Stock Split Dividend History

Bausch Health Companies Inc stock is traded at $6.56, with a volume of 1.65M. It is down -2.96% in the last 24 hours and up +1.86% over the past month. Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.

Previous Close:

$6.76

Open:

$6.71

24h Volume:

1.65M

Relative Volume:

0.51

Market Cap:

$2.45B

Revenue:

$10.53B

Net Income/Loss:

$-1.23B

P/E Ratio:

-2.0209

EPS:

-3.246

Net Cash Flow:

$949.99M

1W Performance:

+3.80%

1M Performance:

+1.86%

6M Performance:

+16.52%

1Y Performance:

-9.02%

1-Day Range:

$6.52

$6.72

1-Week Range:

$6.135

$6.99

52-Week Range:

$4.33

$8.00

Bausch Health Companies Inc Stock (BHC) Company Profile

Name

Bausch Health Companies Inc

Sector

Healthcare (1074)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

514-744-6792

Address

2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC

Employee

20,300

Twitter

Next Earnings Date

2026-07-29

Latest SEC Filings

BHC's Discussions on Twitter

Compare BHC vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BHC Bausch Health Companies Inc	6.56	2.55B	10.53B	-1.23B	949.99M	-3.246
TAK Takeda Pharmaceutical Co Adr	18.45	57.90B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.36	42.89B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.60	43.41B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	75.81	31.00B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	487.61	22.35B	3.17B	1.29B	1.01B	27.09

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-09-25	Initiated	Barclays	Equal Weight
Aug-02-24	Downgrade	Piper Sandler	Neutral → Underweight
Jul-10-24	Initiated	Raymond James	Mkt Perform
Sep-20-23	Upgrade	Jefferies	Hold → Buy
Jun-16-23	Downgrade	TD Cowen	Outperform → Market Perform
Jul-29-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Jul-29-22	Downgrade	Truist	Buy → Hold
Jul-28-22	Downgrade	JP Morgan	Overweight → Neutral
Jun-13-22	Resumed	JP Morgan	Overweight
Mar-24-21	Downgrade	BofA Securities	Neutral → Underperform
Feb-17-21	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Jan-22-21	Downgrade	Piper Sandler	Overweight → Neutral
Sep-17-20	Upgrade	BofA Securities	Underperform → Neutral
Aug-24-20	Reiterated	H.C. Wainwright	Buy
Jun-17-20	Reiterated	H.C. Wainwright	Buy
Apr-24-20	Initiated	Citigroup	Buy
Apr-02-20	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-29-20	Downgrade	Wolfe Research	Outperform → Peer Perform
Jan-22-20	Upgrade	Wells Fargo	Underweight → Equal Weight
Dec-12-19	Upgrade	JP Morgan	Neutral → Overweight
Dec-02-19	Initiated	Goldman	Neutral
Oct-25-19	Initiated	Cowen	Outperform
Sep-12-19	Initiated	Guggenheim	Buy
Aug-15-19	Upgrade	TD Securities	Hold → Buy
Jul-19-19	Initiated	Wolfe Research	Outperform
Jun-11-19	Resumed	Barclays	Overweight
May-13-19	Upgrade	JP Morgan	Underweight → Neutral
Mar-20-19	Initiated	SunTrust	Buy
Jan-02-19	Upgrade	Piper Jaffray	Neutral → Overweight
Nov-05-18	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-13-18	Upgrade	Piper Jaffray	Underweight → Neutral

View All

Bausch Health Companies Inc Stock (BHC) Latest News

Aug 21, 2026

Bausch Health Cos (NYSE:BHC) Insider Aimee Lenar Sells 36,827 Shares - MarketBeat

Aug 20, 2026

Bausch Health Companies Insider Sold Shares Worth $258,894, According to a Recent SEC Filing - marketscreener.com

Aug 20, 2026

FY2026 EPS Estimate for Bausch Health Cos Raised by Analyst - MarketBeat

Aug 20, 2026

Aug 19, 2026

Why Did Bausch Health (TSX:BHC) Stock Surge 5.93% on 18 August 2026? - kalkine.ca

Aug 19, 2026

Bausch Health (NYSE: BHC) officer may sell stock with vested awards listed - Stock Titan

Aug 19, 2026

Bausch Health Stock: A Post-Earnings Rally Extends on a Raised Outlook - kalkine.ca

Aug 19, 2026

Aug 18, 2026

Bausch Health Cos (NYSE:BHC) Trading Up 5.1%Should You Buy? - MarketBeat

Aug 18, 2026

Aug 17, 2026

Is Bausch Health (TSX:BHC) Ready For Resilient Growth? - Kalkine Media

Aug 17, 2026

Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners - AOL.com

Aug 17, 2026

Aug 16, 2026

Bausch Health (BHC) Advances 2.68% as Shares Test Key Resistance at $6.84Leading Diagonal - Vinanet

Aug 16, 2026

Aug 14, 2026

Bausch Health Companies Inc.: Target Price Consensus and Analysts Recommendations | BVF | CA0717341071 - marketscreener.com

Aug 14, 2026

Bausch Health Stock Gains Momentum as Stronger Earnings, Raised Outlook and Debt Progress Lift Investor Optimism - kalkine.ca

Aug 14, 2026

Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month - AOL.com

Aug 14, 2026

Aug 13, 2026

Bausch Health Stock Faces Renewed Pressure as Investor Confidence Weakens - kalkine.ca

Aug 13, 2026

Aug 12, 2026

Bausch Health: Q2 Beat And Cheap, But Debt Overhang Remains Substantial (NYSE:BHC) - Seeking Alpha

Aug 12, 2026

BHC Stock Price Prediction 2025-2026 | Bausch Health Companies Inc Forecast - 24/7 Wall St.

Aug 12, 2026

What Is Fuelling Bausch Health (TSX:BHC) Midcap Interest? - Kalkine Media

Aug 12, 2026

Is Bausch Health (TSX:BHC) Finding Sustainable Pharma Momentum? - kalkinemedia.com

Aug 12, 2026

Bausch Health Stock Faces Renewed Pressure as -1.70% Decline Signals Cautious Investor Sentiment - kalkine.ca

Aug 12, 2026

Aug 11, 2026

Bausch Health Stock Climbs 1.49% as Pharmaceutical Portfolio Strength and Debt Reduction Efforts Boost Investor Confidence - kalkine.ca

Aug 11, 2026